Read + Share
Kander EM, Shah MH, Zhou Y, Goyal A, et al. Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient
With RET Fusion-positive Atypical Lung Carcinoid. Clin Lung Cancer 2021;22:e442-e445.
PMID: 32660930
|
 |
|
Kander EM, Shah MH, Zhou Y, Goyal A, et al. Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient
With RET Fusion-positive Atypical Lung Carcinoid. Clin Lung Cancer 2021;22:e442-e445.
PMID: 32660930
|
|
|
|